Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-6226
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals ; volume:10 ; number:1 ; day:26 ; month:8 ; year:2020 ; pages:1-4 ; date:12.2020
Egyptian liver journal ; 10, Heft 1 (26.8.2020), 1-4, 12.2020
- Urheber
-
Ahmed, Nancy Abdel Fattah
Deiab, Ahmed Galal
Hasan, Ahmad Shawki Mohammad
Elbaky, Ahmad Mohamed Yousry Abd
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43066-020-00051-x
- URN
-
urn:nbn:de:101:1-2020101422022572667946
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ahmed, Nancy Abdel Fattah
- Deiab, Ahmed Galal
- Hasan, Ahmad Shawki Mohammad
- Elbaky, Ahmad Mohamed Yousry Abd
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway